Abrocitinib bulk supplier for pharma manufacturers

Abrocitinib 50 mg, 100 mg, 200 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 50 mg, 100 mg, 200 mg

Reference Brands: Cibinqo (USA/EU)

Abrocitinib is an oral Janus kinase (JAK1) inhibitor used for the treatment of moderate-to-severe atopic dermatitis (eczema) in adults and adolescents. It works by blocking JAK1-mediated cytokine signaling, reducing inflammation, itching, and redness associated with eczema. The drug provides a targeted immune-modulating approach with faster symptom relief compared to conventional immunosuppressants.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Abrocitinib — third party manufacturing & bulk supply

Abrocitinib 50 mg, 100 mg, 200 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Abrocitinib is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Abrocitinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Abrocitinib →

Back to Listing

Frequently Asked Questions

Abrocitinib is listed as Tablets in 50 mg, 100 mg, 200 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Abrocitinib is referenced against Cibinqo (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.